echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The local medical insurance catalog has been adjusted, and a large number of drugs will be out!

    The local medical insurance catalog has been adjusted, and a large number of drugs will be out!

    • Last Update: 2019-12-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] following the release of the national medical insurance catalog, drug price reduction has become a major trend, and many patients are looking forward to the landing of drugs in the medical insurance catalog According to the schedule, 2019 edition of the catalogue is to be officially implemented on January 1, 2020 At present, many local medical insurance catalogues have been greatly adjusted, and a large number of drugs will be out of the market On December 13, Hunan Provincial Medical Insurance Bureau and the Department of human resources and Social Security jointly issued the notice on the implementation of the medical insurance catalogue According to the notice, 20 varieties of the national key monitoring and rational drug use catalogue shall be removed preferentially, and the original catalogue varieties of the province that have entered the National Drug Catalogue shall be classified as "drugs in digestion period" Digests year by year within three years according to the national stipulation According to statistics, a total of 404 drugs (including 212 Western medicines and 192 Chinese patent medicines) are classified as "digest drug catalog" According to the requirements of Hunan Medical Insurance Bureau, 40% of the 404 drugs will be out by 2020 On December 12, Anhui Medical Insurance Bureau issued a notice to clarify that before December 31 this year, on the basis of the current medical insurance drug catalog in Anhui Province, all drugs in the 2019 version of the national medical insurance drug catalog will be included in the scope of the medical insurance catalog From January 1, 2020 At the same time, the notice made clear the digestion arrangement of non-state drug catalogue According to the deployment of Anhui Province, Anhui Medical Insurance Bureau will work out a plan with relevant departments according to the relevant provisions of the state In the next three years, the plan will be gradually digested according to the ratio of 4:4:2, and the national unified drug catalog will be officially implemented from January 1, 2023   In the process of non-state drug catalog digestion, Anhui Medical Insurance Bureau will first cut the varieties of 20 key monitored drugs in the current medical insurance drug catalog of Anhui Province and the four varieties that failed in the negotiation of renewal of the 2017 negotiated access varieties, which will be transferred out before June 30, 2020, and then digest the varieties transferred out of the 2017 national medical insurance catalog, and the drug supervision department will cancel it The variety of approval number and the variety that Anhui health and Health Commission has included in the key monitoring If the above digested varieties are less than 40%, Anhui Medical Insurance Bureau will also organize experts to select the remaining varieties and determine the transferred varieties On December 11, Shandong Medical Insurance Bureau announced that western medicine and Chinese patent medicine in the 2017 medical insurance catalog of Shandong Province have been included in the new national drug catalog according to the national regulations; those not included in the new national drug catalog will be temporarily implemented according to the original regulations, and the provincial medical insurance Bureau will gradually digest them according to the relevant requirements and procedures within three years In the digestion process, priority should be given to adjusting the payment scope of drugs included in the national key monitoring scope According to statistics, 268 drugs (including 143 Western medicines and 125 Chinese patent medicines) in the 2017 medical insurance catalogue of Shandong Province are not included in the new round of national medical insurance catalogue In other words, the 268 drugs mentioned above will gradually be kicked out in three years On December 6, Tianjin Medical Insurance Bureau issued the notice of the municipal human resources and Social Security Bureau of Tianjin Medical Insurance Bureau on docking the national drug catalog of 2019 version, which required that 20 kinds of national key monitoring drugs and the varieties transferred out of the catalog in the current round of national medical insurance catalog adjustment should be removed from the provincial medical insurance catalog In general, with the promotion of policies such as focusing on monitoring drugs and dynamic adjustment of medical insurance catalog, all regions successively abolish the supplementary medical insurance catalog, and the medical market will face upgrading and the survival of the fittest will accelerate.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.